VALUE IN HEALTH
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
Table of contents
- 1
-
Can We Use Social Media to Support Content Validity of Patient-Reported Outcome Instruments in Medical Product Development?Rothman, M. / Gnanaskathy, A. / Wicks, P. et al. | 2015
- 5
-
Applying Dynamic Simulation Modeling Methods in Health Care Delivery Research—The SIMULATE Checklist: Report of the ISPOR Simulation Modeling Emerging Good Practices Task ForceMarshall, D. A. / Burgos-Liz, L. / IJzerman, M. J. et al. | 2015
- 17
-
High-Dose Hemodialysis versus Conventional In-Center Hemodialysis: A Cost-Utility Analysis from a UK Payer PerspectiveLiu, F. X. / Treharne, C. / Arici, M. et al. | 2015
- 25
-
Using Classical Test Theory, Item Response Theory, and Rasch Measurement Theory to Evaluate Patient-Reported Outcome Measures: A Comparison of Worked ExamplesPetrillo, J. / Cano, S. J. / McLeod, L. D. et al. | 2015
- 35
-
Comparing Measurement Properties of the EQ-5D-3L, ICECAP-O, and ASCOT in Frail Older Adultsvan Leeuwen, K. M. / Bosmans, J. E. / Jansen, A. P. et al. | 2015
- 44
-
Measuring Health-Related Quality of Life by Experiences: The Experience Sampling MethodMaes, I. H. / Delespaul, P. A. / Peters, M. L. et al. | 2015
- 52
-
An Exploratory Study to Test the Impact on Three “Bolt-On” Items to the EQ-5DYang, Y. / Rowen, D. / Brazier, J. et al. | 2015
- 61
-
Estimating Quality-Adjusted Life-Year Loss Due to Noncommunicable Diseases in Korean Adults through to the Year 2040Ock, M. / Han, J. W. / Lee, J. Y. et al. | 2015
- 67
-
Pediatricians’ Preferences for Infant Meningococcal VaccinationPoulos, C. / Reed Johnson, F. / Krishnarajah, G. et al. | 2015
- 78
-
Physicians’ Preferences for Bone Metastases Drug Therapy in the United StatesArellano, J. / Hauber, A. B. / Mohamed, A. F. et al. | 2015
- 84
-
Evaluation of Patient Registries Supporting Reimbursement Decisions: The Case of Oxaliplatin for Treatment of Stage III Colon CancerMohseninejad, L. / van Gils, C. / Uyl-de Groot, C. A. et al. | 2015
- 91
-
Risk Attitudes and Personality Traits Predict Perceptions of Benefits and Risks for Medicinal Products: A Field Study of European Medical AssessorsBeyer, A. R. / Fasolo, B. / de Graeff, P. A. et al. | 2015
- 100
-
Determining the Impact of Modeling Additional Sources of Uncertainty in Value-of-Information AnalysisRamos, I. C. / P.M.H., M. / Mölken, R. v. et al. | 2015
- 110
-
Measuring Change in Quality of Life: Bias in Prospective and Retrospective EvaluationBlome, C. / Augustin, M. et al. | 2015
- 116
-
Network Meta-Analysis: Development of a Three-Level Hierarchical Modeling Approach Incorporating Dose-Related ConstraintsOwen, R. K. / Tincello, D. G. / Keith, R. A. et al. | 2015
- 127
-
Optimizing the Leveraging of Real-World Data to Improve the Development and Use of MedicinesBerger, M. L. / Lipset, C. / Gutteridge, A. et al. | 2015
- 130
-
Erratum| 2015
- 131
-
Do the Current Performance-Based Schemes in Italy Really Work? “Success Fee”: A Novel Measure for Cost-Containment of Drug ExpenditureNavarria, A. / Drago, V. / Gozzo, L. et al. | 2015
- i
-
Table of Contents| 2015
- I
-
Instructions for Authors| 2015
-
Copyright/Subscription| 2015
-
Editorial Board| 2015
-
Code of Ethics| 2015